Application of the histone deacetylase inhibitors for the treatment of endometriosis: Histone modifications as pathogenesis and novel therapeutic target

Human Reproduction

Volumn 26, Issue 9, 2011, Pages 2486-2498

  Kawano, Yukie ^a   Nasu, Kaei ^a   Li, Haili ^a   Tsuno, Akitoshi ^a   Abe, Wakana ^a   Takai, Noriyuki ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Endometriosis; epigenetics; histone deacetylase inhibitor; histone modification

Indexed keywords

APICIDIN; CASPASE 9; CYCLE CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE; HISTONE DEACETYLASE INHIBITOR; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; ENDOMETRIOSIS; FEMALE; FLOW CYTOMETRY; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; STROMA CELL; WESTERN BLOTTING;

EID: 80051925953     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der203     Document Type: Article

References (40)

1. Bergqvist A. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol 2000; 14:425-432. (Pubitemid 32165452)
2. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359-383. (Pubitemid 41196955)
3. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107. (Pubitemid 29036293)
4. Choi CH, Burton ZF, Usheva A. Auto-acetylation of transcription factors as a control mechanism in gene expression. Cell Cycle 2004;3:114-115. (Pubitemid 40268675)
5. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799. (Pubitemid 39488065)
6. Gui C-Y, Ngo L, Xu WS, Richon VM, Marks PA. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004;101:1241-1246. (Pubitemid 38182673)
7. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33(Suppl):245-254. (Pubitemid 36278835)
8. Joseph J, Mudduluru G, Antony S, Vashistha S, Ajitkumar P, Somasundaram K. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 2004; 23:6304-6315. (Pubitemid 39215301)
9. Kato N, Fujimoto H, Yoda A, Oishi I, Matsumura N, Kondo T, Tsukada J, Tanaka Y, Imamura M, Minami Y. Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. Cell Death Differ 2004;11:S153-S161.
10. Lemercier C, Brocard MP, Puvion-Dutilleul F, Kao HY, Albagli O, Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem 2003;277:22045-22052.
11. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000;73:1089-1096. (Pubitemid 30336748)
12. Liu X, Guo SW. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril 2007;135:88-93.
13. Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003;13:77-83. (Pubitemid 36143931)
14. Lu Y, Nie J, Liu X, Zheng Y, Guo S-W. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod 2010; 25:1014-1025.
15. Marks PA, Rifkind RA, Richon VM, Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001;7:759-760. (Pubitemid 32708707)
16. Matheu A, Klatt P, Serrano M. Regulation of the INK4a/ARF Locus by Histone Deacetylase Inhibitors. J Biol Chem 2005;280:42433-42441. (Pubitemid 43023216)
17. Nasu K, Tsuno A, Yuge A, Kawano Y, Narahara H. Combined oral contraceptives for the medical treatment of endometriosis-associated pain. Recent Adv Endocrinol Metab 2009;1:1-14.
18. Nishida M, Nasu K, Fukuda J, Kawano Y, Narahara H, Miyakawa I. Down regulation of interleukin-1 receptor expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J Clin Endocrinol Metab 2004;89:5094-5100. (Pubitemid 39391454)
19. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-g-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 2005;11:29-34. (Pubitemid 40331000)
20. Norton VG, Imai BS, Yau P, Bradbury EM. Histone acetylation reduces nucleosome core particle linking number change. Cell 1989;57:449-457. (Pubitemid 19126278)
21. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril 2004;81:1441-1446.
22. Richon VM, O'Brien JP. Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment. Clin Cancer Res 2002;8:662-664. (Pubitemid 34742091)
23. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000;1:11-19.
24. Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 2006;174:341-348. (Pubitemid 43235307)
25. Takai N, Narahara H. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis. Curr Med Chem 2007;14:2548-2553. (Pubitemid 350018467)
26. Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, Miyakawa I, Koeffler HP. Histone deacetylase inhibitors have a profound anti-growth activity in endometrial cancer cells. Clin Cancer Res 2004a;10:1141-1149. (Pubitemid 38198916)
27. Takai N, Kawamata M, Gui D, Said JW, Miyakawa I, Koeffler HP. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Cancer 2004b; 101:2760-2770. (Pubitemid 39603184)
28. Turner BM. Cellular memory and the histone code. Cell 2002; 111:285-291. (Pubitemid 35341385)
29. Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: versatile regulators. Trends Genet 2003;19:286-293. (Pubitemid 36507011)
30. Warrener R, Beamish H, Burgess A, Waterhouse NJ, Giles N, Fairlie D, Gabrielli B. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. FASEB J 2003;17:1550-1552.
31. Wu Y, Guo SW. Suppression of IL-1b-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol 2007;135:88-93. (Pubitemid 350026147)
32. Wu Y, Guo SW. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol 2008; 137:198-203. (Pubitemid 351423449)
33. Wu Y, Guo SW. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells. Fertil Steril 2009; 91(Suppl):2142-2147.
34. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006;1:106-111.
35. Wu Y, Starzinski-Powitz A, Guo S-W. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci 2007a;14:374-382. (Pubitemid 351168805)
36. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 2007b; 87:24-32. (Pubitemid 46013877)
37. Wu Y, Starzinski-Powitz A, Guo S-W. Prolonged stimulation with tumor necrosis factor-a induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril 2008; 90:234-237. (Pubitemid 351885197)
38. Wu Y, Starzinski-Powitz A, Guo S-W. Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappab in immortalized endometriotic cells and their suppression by trichostatin A. Gynecol Obstet Invest 2010;70:23-33.
39. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 2007a;77:681-687. (Pubitemid 47494383)
40. Xue Q, Lin Z, Yin P, Milad MP, Cheng Y-H, Confino E, Reierstad S, Bulun SE. Transcriptional Activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab 2007b;92:3261-3267. (Pubitemid 47236401)